Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy.

Luis E EcheverríaLyda Z RojasSergio Alejandro Gómez-OchoaOscar L Rueda-OchoaCristian David Sosa-VesgaTaulant MukaJames L JanuzziRachel MarcusCarlos A Morillo

Published in: PloS one (2021)

The combination of NT-proBNP and hs-TnT above their selected cut-off values is associated with a 3-fold increase in the risk of the composite outcome among CCM patients. The use of cardiac biomarkers may improve prognostic evaluation of patients with CCM.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
peritoneal dialysis
left ventricular
patient reported outcomes
patient reported
atrial fibrillation